Karyopharm: Xpovio Revenue Stagnation And Toxicity Concerns Justify Sell
Karyopharm Therapeutics Inc KPTI
$9.02
▼ -4.04%
($-0.38)
Open
$9.60
Prev Close
$9.40
Day Range
$8.90 – $9.74
52W Range
$3.65 – $10.99
Market Cap
$204.42M
Beta
0.84
EPS (TTM)
$-14.84
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2013-11-06 |
| Shares Out. | 22,660,000 |
| Website | karyopharm.com/ ↗ |
| Phone | 13026587581 |
Karyopharm Therapeutics Inc is a publicly traded company under the ticker symbol KPTI on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-06-01)